Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Targeting the Warburg effect in anaplastic thyroid carcinoma may reduce tumor growth and improve treatment.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Mast cells influence skin aging and are potential targets for anti-aging treatments.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

Regenerative medicine may offer long-lasting relief for chronic pain and neuro-degenerative conditions.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

New treatments for hair loss are emerging as we better understand hair growth and its genetic causes.

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Microneedle patches could replace injections but need more development for better use in medicine.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Light therapy can help heal soft tissue injuries and reduce pain and inflammation.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

A woman got melanoma on her scalp after anti-hair loss treatment with injections.

Abrocitinib may effectively treat stubborn alopecia universalis.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.